A Descriptive & clinical study of HIV patients in Damascus and the effect of Dolutegravir & Abacavir on CD4+ titer-Reference-Cited by-同舟云学术

A Descriptive & clinical study of HIV patients in Damascus and the effect of Dolutegravir & Abacavir on CD4+ titer

Published:2022-10-24 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Almouli Rahem¹,Domirieh Ahmad¹,Aldahr Nizar¹,Al-Manasfi Anas¹

Affiliation:

1. Syrian Private University

Abstract

Abstract Background: AIDS is one of the diseases of concern worldwide, as the number of people infected with HIV around the world reached about 38.4 million until 2021, and new infections this year were about one and a half million. Design: A Cross-Sectional and prospective Study conducted in Syria. Methods: (150) HIV patients registered at the AIDS Control Center in Damascus and patients in the septic division of Al-Mowasat University Hospital until 15/8/2022. Results: The results were classified in statistical tables and graphs, which we will summarize as follows: • The largest percentage of AIDS patients in Damascus are males, 80.7%. • The largest percentage was diagnosed in 2018 and 2019. • Improved CD4+ values in patients who were put on the current protocol, Dolutegravir+Abacavir.

Publisher

Research Square Platform LLC

Reference10 articles.

1. Technical consultation on methods for generating sub-national estimates of HIV epidemiology to support country programme planning and evaluation;HIV modelling consortium;Kenya,2015

2. Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study;Anderson SJ;Lancet,2014

3. Revill P, Hallett T, Phillips A and the HIV Modelling Consortium in collaboration with the working group on modelling of ART monitoring strategies in Sub-Saharan Africa. The costs and benefits of alternative approaches to monitoring patients on antiretroviral therapy: modelling and economic analysis, A HIV Modelling Consortium report for the World Health Organization HIV Treatment Guidelines Development Committee, 2015. (http://www.hivmodelling.org/sites/default/files/uploads/documents/meeting-reports/ HIV%20MC%20WSII%20GRC%20Report_2015.pdf, accessed 16 February 2016).

4. Sustainable HIV treatment in Africa through viral load– informed differentiated care;Phillips A;Nature,2015

5. National AIDS Council, Zimbabwe. Operational and Service Delivery Manual for the Prevention, Care and Treatment of HIV in Zimbabwe, 2015. (http://www.nac.org.zw/program-areas/treatment-care-support, accessed 16 February 2016).